Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
DBV Technologies S.A. (DBVT)
|
Add to portfolio |
|
|
|
| Price: |
$5.89
| | Metrics |
| OS: |
94.1
|
M
| |
|
|
| Market cap: |
$555
|
M
| |
|
|
|
Net cash:
|
$192
|
M
| |
$2.04
|
per share
|
|
EV:
|
$362
|
M
| | | |
| | | | | |
| TTM Valuation | | | |
|
EBITDA
|
($75.6)
|
M
| |
|
|
|
EBIT
|
|
| |
|
|
| EPS |
| |
|
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
| In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-16 | Dec-31-15 | Dec-31-14 | Dec-31-13 |
| Revenues | 4.8 | 5.7 | 11.3 | 14.7 | 9.1 | 0.2 | 0.2 | 27.6 |
| Revenue growth | -15.1% | -49.4% | -23.3% | | 4397.0% | -4.3% | -99.2% | 45.6% |
| Cost of goods sold | -103.3 | -108.0 | 0.0 | -186.3 | 0.0 | 0.1 | 0.1 | -0.1 |
| Gross profit | 108.1 | 113.8 | 11.3 | 201.0 | 9.1 | 0.1 | 0.1 | 27.7 |
| Gross margin | 2231.7% | 1992.8% | 100.0% | 1366.4% | 100.0% | 36.6% | 35.5% | 100.4% |
| Sales and marketing | 1.6 | 4.4 | 9.9 | 21.6 | 11.3 | 0.5 | 0.0 | |
| Research and development | 75.5 | 70.3 | 101.6 | 115.1 | 78.8 | 34.2 | 21.1 | 17.4 |
| General and administrative | 24.3 | 30.5 | 35.1 | 49.1 | 35.0 | 16.9 | 8.1 | 6.3 |
| EBIT | -94.8 | -95.8 | -155.5 | -170.5 | -116.0 | -45.5 | -24.6 | 3.8 |
| EBIT margin | -1958.1% | -1678.6% | -1379.1% | -1159.1% | -1277.3% | -22547.5% | -11675.8% | 13.9% |
| Pre-tax income | -96.2 | -98.2 | -159.6 | -171.4 | -114.5 | -44.7 | -24.0 | -19.3 |
| Income taxes | 0.1 | 0.4 | 0.0 | 0.6 | 0.0 | 0.0 | 0.0 | 0.0 |
| Tax rate | | | | | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | -96.3 | -97.8 | -159.6 | -172.0 | -114.5 | -44.7 | -24.0 | -19.3 |
| Net margin | -1987.5% | -1713.5% | -1415.0% | -1169.5% | -1260.8% | -22115.8% | -11380.1% | -69.9% |
| |
| Diluted EPS | ($1.24) | ($1.78) | ($2.95) | ($4.65) | | | | ($1.42) |
| Shares outstanding (diluted) | 77.4 | 54.9 | 54.1 | 37.0 | | | | 13.6 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|